![]()
MIRA INFORM
REPORT
|
Report Date : |
07.03.2011 |
IDENTIFICATION DETAILS
|
Name : |
|
|
|
|
|
Registered Office : |
5th
Floor, Nelson Chamber, |
|
|
|
|
Country : |
|
|
|
|
|
Year of Establishment : |
1963 |
|
|
|
|
Com. Reg. No.: |
0001681 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacture & Marketing of Pharmaceutical Products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
|
b2 |
b2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Registered
Address |
|
5th
Floor, Nelson Chamber, |
|
Tel |
92 (21) 2624445, 2624062 |
|
Fax |
92 (21)
2635851 |
|
Website |
|
a. |
Nature of Business |
Manufacture & Marketing of Pharmaceutical Products |
|
b. |
Year Established |
1963 |
|
c. |
Registration # |
0001681 |
|
Address |
D-122, S.I.T.E., |
|
Tel # |
92 (21) 2582023 |
|
Fax # |
92 (21) 2564650 |
M/s Munif Ziauddin & Co.
(Chartered
Accountants)
Business Executive
Centre, F/17/3, Block 8,
Subject Company was established as a Private Limited Company in 1963
|
Authorized Capital |
Rs. 5,000,000/-
divided into 5,000 shares of Rs. 1000/- each |
|
Issued & Paid up Capital |
Rs. 4,377,000/-
divided into 4,377 shares of Rs. 1000/- each |
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Muhammad Yahya Mr. Muhammad Ilyas Mr. Owais A. Allawala |
Pakistani Pakistani Pakistani |
5th
Floor, Nelson Chambers, 5th
Floor, Nelson Chambers, 5th
Floor, Nelson Chambers, |
Business Business Business |
Chief Executive Director Director |
|
Names |
No. of Shares |
|
Mr. Muhammad Rafi Mr. Muhammad Yahya Mr. Muhammad Ilyas Mrs. Ameena Begum Miss Zia Khatoon Miss Nayyar Khatoon Mr. Muhammad Essa Mrs. Salma Ruby Mr. Owais A. Allahwala |
41 97 41 92 67 75 355 100 1,529 2,000 |
A. Subsidiary
None
B. Associated
Companies
(1) M/S
ARCOFIX, ARCOFLOXIN, ARCOMOX, ARCOZID, ARCOZOL, BETABLOCK, CALCIUM ARCO, CEPADIN, CLORAMIDINA, CLORAMIDINA H, DOLGIT, FAMDIN, GASTRUSIL, HADENSA FORTE, HADENSA PLAIN, KATIFEN, LOPERAM, NECLOF, SEPTEM, THEORON, VITAFER
130
(Foreign)
·
VASUDHA
·
MURLI KRISHNA (PVT) LIMITED,
·
ZHUHAI UNITED LABORATORIES CO., LTD,
The capacity and production of the company’s plant is
indeterminable as it involves varying processes of manufacture.
|
Year |
In Pak Rupees |
|
2009 |
100,000,000/- (Estimated) |
Mainly in
·
Habib Bank Limited,
·
Habib Metropolitan Bank Limited,
·
Citibank N.A.,
·
Soneri Bank Limited,
·
·
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 85.40 |
|
|
1 |
Rs. 138.25 |
|
Euro |
1 |
Rs. 118.72 |
Subject Company was established in 1963 and is engaged in manufacture & marketing of Pharmaceutical Products. Overall reputation is normal. Trade relations are reported as fair. Company can be considered for normal business dealings at usual trade terms & conditions.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.99 |
|
|
1 |
Rs.73.24 |
|
Euro |
1 |
Rs.62.80 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.